Best Weight Loss Clinics in Pennsylvania 2026

Best Weight Loss Clinics in Pennsylvania 2026: Philadelphia, Pittsburgh & Statewide

Pennsylvania’s weight loss landscape in 2026 looks different depending on where you live. In Philadelphia, you can choose between Penn Medicine, Jefferson, and Temple academic obesity programs within a few miles of one another. In Pittsburgh, UPMC and Allegheny Health Network dominate, with multidisciplinary clinics across the region. In rural central and northern PA, your nearest in-person obesity medicine specialist may be 60 miles away, which makes Geisinger and telehealth platforms the practical default. This guide maps the best weight loss clinics across Pennsylvania, explains how PA Medicaid (Medical Assistance) handles GLP-1 coverage in 2026, and outlines the state’s telehealth prescribing rules.

Key takeaways for 2026

• Pennsylvania’s adult obesity rate is approximately 32%, slightly above the national average, with higher rates in central and western counties.
• Penn Medicine’s Comprehensive Weight Management Program and UPMC’s Bariatric and Metabolic Surgery program anchor the two metro areas.
• Geisinger provides the most cohesive obesity care across rural PA, with strong telehealth integration and value-based GLP-1 access.
• PA Medical Assistance covers Wegovy and Zepbound with prior authorization in 2026, with a relatively less restrictive preferred drug list compared to neighboring states.
• Cash-pay telehealth GLP-1 prescriptions in PA generally run $200-$450 per month for compounded or branded products.
• PA’s Act 76 of 2019 created the state’s telehealth framework, requiring prescribers to hold a PA license to treat patients located in Pennsylvania.

Weight loss in Pennsylvania — the regional picture

According to the Pennsylvania Department of Health, roughly 32% of adults statewide have obesity (BMI 30+), with prevalence climbing in counties along the I-80 corridor and in the southwest. Type 2 diabetes prevalence is also elevated in central PA, which is part of why GLP-1 receptor agonists like semaglutide and tirzepatide have become so widely prescribed in the state.

Care access splits along three lines. Philadelphia and its suburbs (Montgomery, Bucks, Chester, Delaware counties) have a dense ecosystem of academic medical centers and private bariatric practices. Pittsburgh and the southwest are dominated by two integrated health systems — UPMC and AHN — that operate dozens of obesity-medicine touchpoints. The middle of the state, including the Northern Tier, Wilds region, and parts of central PA, is largely served by Geisinger, smaller community hospitals, and telehealth.

Insurance coverage is also fragmented. Independence Blue Cross dominates the Philadelphia region, Highmark Blue Cross Blue Shield dominates the Pittsburgh and western PA market, and Geisinger Health Plan covers much of the central and northeastern parts of the state. Each has different rules for GLP-1 prior authorization.

Philadelphia metro weight loss clinics

Penn Medicine Comprehensive Weight Management Program — Based at the Hospital of the University of Pennsylvania, this is one of the longest-running academic obesity centers in the country. It offers medical weight management, intensive behavioral therapy, GLP-1 prescribing, and bariatric surgery (sleeve gastrectomy, Roux-en-Y, revisional surgery) under one roof. The program is also a frequent site for obesity pharmacotherapy clinical trials.

Jefferson Health (Thomas Jefferson University Hospital) — Jefferson’s Bariatrics and Metabolic program covers surgical and non-surgical obesity care across Center City and suburban Philadelphia locations. The program integrates endocrinology, nutrition, and behavioral health, and is well suited to patients with significant metabolic comorbidities.

Temple University Hospital — Temple’s Bariatric Program in North Philadelphia is a Center of Excellence for bariatric surgery and operates a medical weight loss arm with GLP-1 prescribing and structured lifestyle counseling. Temple’s location makes it a key access point for residents of North and West Philadelphia.

Cooper University Health Care — Although technically based in Camden, NJ, Cooper functions as a major weight-loss provider for South Jersey and Philadelphia metro residents. Its Bariatric and Metabolic Surgery Center operates a comprehensive medical and surgical program with an MBSAQIP accreditation.

Penn State Health — Penn State Health Milton S. Hershey Medical Center and its Lancaster Medical Center offer obesity medicine for the southeastern part of the state outside Philadelphia proper. Their multidisciplinary program is a useful option for patients in Lancaster, Berks, and Dauphin counties.

Pittsburgh metro weight loss clinics

UPMC (University of Pittsburgh Medical Center) — UPMC operates the largest obesity care footprint in western PA. Its Bariatric and Metabolic Institute, based at UPMC Magee-Womens and other locations, performs thousands of bariatric procedures annually and runs medical weight management clinics across more than a dozen Pittsburgh-area sites. UPMC also operates obesity programs in Harrisburg, Williamsport, Altoona, and Erie, giving it the broadest geographic reach of any PA system.

Allegheny Health Network (Highmark) — AHN’s Bariatric and Weight Management Institute, with locations at West Penn, Allegheny General, Forbes, and Jefferson hospitals, is the main alternative to UPMC in the Pittsburgh market. As part of the Highmark integrated network, AHN often has favorable coverage pathways for Highmark Blue Cross Blue Shield members.

Children’s Hospital of Pittsburgh of UPMC — For adolescent obesity, the Weight Management and Wellness Center at Children’s Hospital is one of the most comprehensive pediatric programs in the eastern US. It offers medical management, family-based behavioral treatment, and adolescent bariatric surgery for patients who meet criteria.

West Penn Hospital — Part of AHN, West Penn houses one of the network’s busiest bariatric programs and a medical weight loss clinic with anti-obesity medication prescribing.

Other PA metros

Allentown / Lehigh Valley — Lehigh Valley Health Network (LVHN) operates a Bariatric Medicine and Nutrition program with surgical and non-surgical tracks. St. Luke’s University Health Network is the regional competitor, with bariatric programs at its Bethlehem and Allentown campuses.

Erie — UPMC Hamot and AHN Saint Vincent both run obesity programs in Erie. UPMC Hamot has a bariatric Center of Excellence designation, while Saint Vincent is the more accessible Highmark-aligned option.

Harrisburg — UPMC Harrisburg (formerly Pinnacle Health) and Penn State Health both offer comprehensive obesity care for the capital region. Penn State Health is the better choice for patients who want academic-style multidisciplinary care.

Scranton/Wilkes-Barre — Geisinger is the dominant provider in the Northeast region. Its Center for Nutrition and Weight Management offers obesity medicine, bariatric surgery, and integrated GLP-1 prescribing under one umbrella.

Geisinger — rural PA’s primary obesity medicine access

Geisinger is one of the most important weight-loss providers in Pennsylvania because of its rural reach. Headquartered in Danville and serving 45+ counties, Geisinger operates obesity medicine clinics at Danville, Scranton, State College, Wilkes-Barre, and several smaller community hospitals. Because Geisinger operates as a value-based integrated system, its physicians have well-defined GLP-1 prescribing pathways and the system’s Geisinger Health Plan covers semaglutide and tirzepatide with prior authorization for qualifying patients.

Geisinger is also notable for its MyCode Community Health Initiative, a large-scale genomic research project that has enrolled hundreds of thousands of PA residents. Patients in the obesity medicine program may be eligible to participate in MyCode-linked studies on metabolic disease.

For rural PA residents, Geisinger’s telehealth platform allows obesity-medicine follow-ups, dietitian visits, and behavioral health appointments to be conducted from home — important when the nearest in-person specialist may be a 90-minute drive.

Telehealth services serving Pennsylvania

For Pennsylvanians who want fast access to GLP-1 prescribing without going through an academic center, a number of telehealth platforms operate in the state with PA-licensed prescribers:

• Hims — Branded and compounded GLP-1 options, integrated with general men’s health services.
• Ro — One of the larger national platforms; Ro’s Body program provides clinical management with Wegovy and Zepbound.
• Hers — Sister brand to Hims, focused on women’s metabolic and weight care.
• Henry Meds — Compounded semaglutide and tirzepatide where legally permitted; cash-pay model.
• Remedy Meds — Cash-pay GLP-1 telehealth with PA coverage.
• Mochi Health — Obesity medicine-led telehealth, broader formulary including non-GLP-1 options like phentermine and metformin where appropriate.

Each of these platforms requires an evaluation by a PA-licensed clinician before prescribing.

Pennsylvania Medicaid GLP-1 coverage in 2026

Pennsylvania’s Medicaid program, known as Medical Assistance (MA), is administered by the Department of Human Services and uses a Preferred Drug List (PDL) updated by the Pharmacy and Therapeutics Committee. In 2026, Wegovy (semaglutide) and Zepbound (tirzepatide) are both covered for obesity indications with prior authorization. Typical prior-authorization criteria include a BMI of 30 or above (or 27+ with a qualifying comorbidity such as type 2 diabetes, hypertension, or dyslipidemia), documented lifestyle intervention, and clinician attestation.

Compared to several neighboring states that excluded anti-obesity medications from Medicaid coverage entirely, PA’s approach is relatively less restrictive. The recent expansion of obesity-medicine coverage by PA Medical Assistance reflects a broader public health push to address the state’s diabetes and cardiovascular disease burden. Coverage details and PA criteria are documented on the Pennsylvania Department of Human Services Medical Assistance PDL.

Pennsylvania telehealth prescribing rules

Telehealth in Pennsylvania is governed by Act 76 of 2019 (technically codified through subsequent regulations) and overseen by the Pennsylvania State Board of Medicine and State Board of Osteopathic Medicine. Key rules for patients seeking weight-loss prescriptions via telehealth include:

• The prescriber must hold a current PA medical license, regardless of where they are physically located. An out-of-state physician cannot prescribe to a PA patient without PA licensure (or use of an interstate compact pathway where applicable).
• An audiovisual or appropriate clinical interaction is required to establish the patient-prescriber relationship before prescribing.
• For Schedule IV controlled substances like phentermine, federal DEA rules layer on top of state rules. As of 2026, telehealth prescribing of Schedule IV stimulants is permitted under federal extensions, but practices typically require at least one in-person evaluation within a defined window.
• GLP-1 medications (semaglutide, tirzepatide, liraglutide) are not controlled substances and have fewer telehealth prescribing restrictions.

Patients should confirm that any telehealth platform they use has a PA-licensed clinician on the prescribing end.

Cost of weight loss treatment in Pennsylvania

Cash-pay costs for GLP-1 telehealth in PA generally fall in a $200-$450/month range. Compounded semaglutide is at the lower end (often $200-$300), branded Wegovy or Zepbound through manufacturer savings programs sits at $499-$650/month, and full retail without coupons can exceed $1,000/month.

Insurance coverage varies significantly by region. Highmark Blue Cross Blue Shield (dominant in Pittsburgh and western PA) and Independence Blue Cross (dominant in Philadelphia) have different prior-authorization criteria and different formulary preferences. Highmark members using AHN-affiliated providers often have a smoother coverage path, just as Independence Blue Cross members using Penn Medicine or Jefferson are well-supported in-network. Geisinger Health Plan members benefit from integrated obesity care within Geisinger’s system.

Penn Medicine and UPMC academic obesity programs typically charge office-visit fees in the $200-$400 range for new patient consults, with follow-up costs of $100-$200, much of which is insurance-covered for in-network patients.

Rust Belt context: obesity, diabetes, and GLP-1

Pennsylvania has high obesity and type 2 diabetes prevalence in many former industrial communities — Pittsburgh’s Mon Valley, Scranton, Erie, and a number of central PA counties. GLP-1 receptor agonists like semaglutide and tirzepatide are dual-purpose drugs: they were initially approved for type 2 diabetes (Ozempic, Mounjaro) and later for chronic weight management (Wegovy, Zepbound). For patients who have both conditions — a common scenario in PA — coverage may be available through the diabetes indication even when obesity-only coverage is restricted.

This dual-pathway prescribing is a significant access lever for PA patients and is one reason clinicians at Geisinger, UPMC, and Penn Medicine frequently start patients on these medications when both diagnoses are present.

Cold-climate management

Pennsylvania winters, especially in the higher elevations of the Laurel Highlands, the Pocono region, and the Northern Tier, can disrupt outdoor exercise routines for several months. Clinicians often recommend leveraging indoor infrastructure — Y’s, county recreation centers, hospital-affiliated wellness centers, and home-based exercise programs — to maintain activity during the cold months. Vitamin D status is also worth monitoring during the long PA winters, as lower levels are common and have been linked to weight regulation pathways.

Frequently asked questions

Does PA Medicaid cover Wegovy in 2026?
Yes. Pennsylvania Medical Assistance covers Wegovy with prior authorization in 2026, with criteria typically including BMI thresholds and documented lifestyle intervention. Zepbound is also covered under PA. Confirm current criteria on the PA MA Preferred Drug List.

Penn Medicine vs UPMC for weight loss — which is better?
Both are top-tier academic obesity programs. Penn Medicine is generally the leading choice for Philadelphia metro residents and patients seeking access to clinical trials, while UPMC’s geographic footprint (covering Pittsburgh, Harrisburg, Erie, and beyond) gives it the widest access across western and central PA. Insurance network matters: Penn aligns with Independence Blue Cross; UPMC has its own health plan and is in-network with several other carriers.

Where can I get GLP-1 prescribed in central or rural PA?
Geisinger is the most established in-person option for central and northeastern PA. Telehealth platforms (Ro, Hims, Mochi, Henry Meds) are practical alternatives for residents who don’t have a nearby obesity specialist. Geisinger’s own telehealth services are an additional option for existing Geisinger patients.

Can I get phentermine via telehealth in PA?
Yes, but with caveats. Phentermine is a Schedule IV controlled substance, and PA telehealth platforms that prescribe it generally require strict screening and may require at least one in-person evaluation. Mochi and some specialty platforms include phentermine in their formulary for appropriate patients.

Best weight loss clinic near Pittsburgh?
UPMC’s Bariatric and Metabolic Institute and Allegheny Health Network’s Bariatric and Weight Management Institute are the two leading options. UPMC has the broader geographic footprint and is often preferred for surgical care; AHN is the natural fit for Highmark members.

Is Geisinger good for obesity medicine?
Geisinger is one of the strongest integrated obesity care providers in the country, particularly for patients in central and northeast PA. Its value-based model means coordinated GLP-1 prescribing, dietitian access, and behavioral health under one roof, with telehealth options for rural patients.

How much does Penn Medicine’s weight loss program cost?
New patient consults at Penn Medicine’s Comprehensive Weight Management Program typically run $200-$400 before insurance, with most in-network patients paying only their copay or coinsurance. Out-of-pocket costs for GLP-1 medications depend on insurance and manufacturer programs.

Does Highmark cover Wegovy in PA?
Highmark Blue Cross Blue Shield plans vary by employer and product, but most commercial Highmark plans cover Wegovy with prior authorization in 2026. Medicare Advantage products from Highmark generally do not cover anti-obesity medications for weight loss alone.

Medical disclaimer and affiliate disclosure

This article is for informational purposes only and is not medical advice. Weight loss medications, including GLP-1 receptor agonists, have potential side effects and contraindications. Consult a licensed physician or other qualified healthcare provider before starting or changing any weight loss treatment. Pennsylvania residents should verify clinician licensure with the Pennsylvania State Board of Medicine.

BestMDHub may earn a commission from telehealth providers or other partners linked in this article. This does not affect editorial selection or the clinical information provided. Sources referenced include the Pennsylvania Department of Health, the Pennsylvania Department of Human Services Medical Assistance Preferred Drug List, and the Pennsylvania State Board of Medicine.